Evidence map›Paper›PMID 22057328›Full record

ReviewPlant signaling & behavior2011

Plant TOR signaling components.

Florian John, Stefan Roffler, Thomas Wicker, Christoph Ringli

Open access · bronzeAbstract readReview
In one paragraph

Review in Plant signaling & behavior, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Contributions of TOR Signaling on Photosynthesis.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Review
  10. Molecular and Hormonal Regulation of Leaf Morphogenesis in Arabidopsis.International journal of molecular sciences · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Size control in plants--lessons from leaves and flowers.Cold Spring Harbor perspectives in biology · 2015
    Review
  17. A phyletic perspective on cell growth.Cold Spring Harbor perspectives in biology · 2015
    Review
  18. Metabolic scaling theory in plant biology and the three oxygen paradoxa of aerobic life.Theory in biosciences = Theorie in den Biowissenschaften · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Florian JohnInstitute of Plant Biology, University of Zürich, Zürich, Switzerland.
Stefan Roffler
Thomas Wicker
Christoph Ringli
University of Zurich · CHInstitute of Plant Biology · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell growth is a process that needs to be tightly regulated. Cells must be able to sense environmental factors like nutrient abundance, the energy level or stress signals and coordinate growth accordingly. The Target Of Rapamycin (TOR) pathway is a major controller of growth-related processes in all eukaryotes. If environmental conditions are favorable, the TOR pathway promotes cell and organ growth and restrains catabolic processes like autophagy. Rapamycin is a specific inhibitor of the TOR kinase and acts as a potent inhibitor of TOR signaling. As a consequence, interfering with TOR signaling has a strong impact on plant development. This review summarizes the progress in the understanding of the biological significance and the functional analysis of the TOR pathway in plants.

Indexed as

Signal TransductionCell WallPlant CellsPlant ProteinsPlantsSirolimusTOR Serine-Threonine KinasesPlant ProteinsSirolimusTOR Serine-Threonine Kinases

Identifiers

PMID22057328
PMCPMC3329340
OpenAlexW2058674308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.